| Date Filed | Type | Description |
| 06/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2016 |
4
| IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 25,299 options to buy
@ $78.91, valued at
$2M
Granted 5,000 options to buy
@ $0 |
|
| 04/05/2012 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 1,557 shares
@ $38.23, valued at
$59.5k
|
|
| 03/09/2012 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 607 shares
@ $34.71, valued at
$21.1k
|
|
| 03/07/2012 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 1,319 shares
@ $35.01, valued at
$46.2k
|
|
| 03/05/2012 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 1,530 shares
@ $34.95, valued at
$53.5k
Paid exercise price by delivering 1,108 shares
@ $34.95, valued at
$38.7k
|
|
| 03/02/2012 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Granted 33,056 shares
@ $0 |
|
| 02/29/2012 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 5,615 shares
@ $33.81, valued at
$189.8k
|
|
| 05/17/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/06/2011 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 788 shares
@ $33.19, valued at
$26.2k
|
|
| 03/08/2011 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 805 shares
@ $31.24, valued at
$25.1k
Paid exercise price by delivering 461 shares
@ $30.76, valued at
$14.2k
|
|
| 02/09/2011 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 290 shares
@ $27.64, valued at
$8k
|
|
| 07/23/2010 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 284 shares
@ $24.63, valued at
$7k
|
|
| 04/06/2010 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 454 shares
@ $25.02, valued at
$11.4k
|
|
| 03/09/2010 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 464 shares
@ $23.09, valued at
$10.7k
Paid exercise price by delivering 354 shares
@ $23.09, valued at
$8.2k
|
|
| 03/03/2010 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Granted 48,479 shares
@ $0 |
|
| 03/02/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2010 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP|
Txns:
| Paid exercise price by delivering 345 shares
@ $22.27, valued at
$7.7k
|
|
| 07/23/2009 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP |
| 04/07/2009 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP |
| 03/10/2009 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP |
| 03/10/2009 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP |
| 03/03/2009 |
4
| IPPOLITO VINCENT P (EVP, Sales & Marketing) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP |